BlogInvestingPersonal FinanceStock MarketUnited States

Gujarat Kidney and Super Speciality IPO Subscribed 58% on Day 1; Retail Portion Booked 2x, GMP in Focus

The Gujarat Kidney and Super Speciality IPO saw a steady response on its opening day, with the issue getting 58 percent subscribed on Day 1 so far. Strong interest from individual investors stood out, as the retail investor portion was subscribed nearly 2 times within the first day of bidding.

The healthcare services company has launched the IPO to raise Rs 250.80 crore, entirely through a fresh issue of equity shares. Proceeds from the issue are expected to be used for business expansion, capacity enhancement, and general corporate purposes.

Gujarat Kidney IPO: Investor Interest and GMP Trend

Market participants are closely tracking the grey market premium (GMP) of the Gujarat Kidney and Super Speciality IPO to gauge potential listing gains. While GMP trends remain volatile, the healthy retail participation reflects positive sentiment toward healthcare IPOs amid a selective primary market.

The IPO subscription will remain open for bidding over the next few sessions, with institutional demand likely to determine the final subscription numbers.

Keywords: Gujarat Kidney IPO, Gujarat Kidney and Super Speciality IPO subscription, Gujarat Kidney IPO GMP, healthcare IPO India, IPO news today, retail investor demand, upcoming IPOs India

Related posts

Zomato founder Deepinder Goyal is in discussions to invest in Pixxel’s ongoing fundraising round, which is expected to raise over $55 million, according to sources cited by Moneycontrol.

Uttam

SEBI Board Meeting: Mutual Fund Rules, Broker Norms and Conflict-of-Interest Code on Agenda

Uttam

Here’s a quick summary of the Budget 2026 focus, according to Quest’s Rakesh Vyas:

Uttam

Leave a Comment